Cubist Systematic Strategies, LLC Teva Pharmaceutical Industries LTD Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 116,569 shares of TEVA stock, worth $2.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
116,569
Previous 116,569 -0.0%
Holding current value
$2.04 Million
Previous $1.89 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$12.78 - $17.4 $3.22 Million - $4.39 Million
-252,181 Reduced 68.39%
116,569 $1.89 Million
Q1 2024

May 15, 2024
SELL
$10.67 - $14.43 $3.96 Million - $5.35 Million
-370,972 Reduced 50.15%
368,750 $5.2 Million
Q4 2023

Feb 14, 2024
BUY
$8.12 - $10.63 $2.16 Million - $2.82 Million
265,527 Added 56.0%
739,722 $7.72 Million
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $5.36 Million - $7.66 Million
-716,236 Reduced 60.17%
474,195 $4.84 Million
Q2 2023

Aug 14, 2023
BUY
$7.2 - $9.47 $1.53 Million - $2.02 Million
213,120 Added 21.81%
1,190,431 $8.96 Million
Q1 2023

May 15, 2023
BUY
$8.36 - $11.37 $4.23 Million - $5.76 Million
506,375 Added 107.53%
977,311 $8.65 Million
Q4 2022

Feb 14, 2023
SELL
$7.95 - $9.48 $2.2 Million - $2.62 Million
-276,499 Reduced 36.99%
470,936 $4.29 Million
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $4.4 Million - $7.66 Million
641,282 Added 604.11%
747,435 $6.03 Million
Q2 2022

Aug 15, 2022
SELL
$7.38 - $10.4 $22,398 - $31,564
-3,035 Reduced 2.78%
106,153 $798,000
Q1 2022

May 16, 2022
SELL
$7.33 - $9.39 $1.66 Million - $2.12 Million
-226,045 Reduced 67.43%
109,188 $1.03 Million
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $2.34 Million - $3.01 Million
-295,630 Reduced 46.86%
335,233 $2.69 Million
Q3 2021

Nov 15, 2021
BUY
$8.38 - $10.18 $5.1 Million - $6.2 Million
608,631 Added 2737.63%
630,863 $6.15 Million
Q2 2021

Aug 16, 2021
BUY
$9.9 - $11.56 $43,134 - $50,366
4,357 Added 24.37%
22,232 $220,000
Q1 2021

May 17, 2021
SELL
$10.34 - $12.81 $174,373 - $216,027
-16,864 Reduced 48.54%
17,875 $206,000
Q4 2020

Feb 16, 2021
SELL
$8.61 - $11.04 $478,698 - $613,801
-55,598 Reduced 61.55%
34,739 $335,000
Q3 2020

Nov 16, 2020
SELL
$8.57 - $12.69 $3.32 Million - $4.92 Million
-387,466 Reduced 81.09%
90,337 $814,000
Q2 2020

Aug 14, 2020
SELL
$8.12 - $13.12 $1.07 Million - $1.73 Million
-131,479 Reduced 21.58%
477,803 $5.89 Million
Q1 2020

May 15, 2020
SELL
$6.69 - $13.45 $1.31 Million - $2.63 Million
-195,368 Reduced 24.28%
609,282 $5.47 Million
Q4 2019

Feb 14, 2020
SELL
$6.53 - $10.72 $2.37 Million - $3.89 Million
-362,759 Reduced 31.07%
804,650 $7.89 Million
Q3 2019

Nov 14, 2019
BUY
$6.16 - $9.6 $5.45 Million - $8.5 Million
885,535 Added 314.16%
1,167,409 $8.03 Million
Q2 2019

Aug 14, 2019
BUY
$8.12 - $15.72 $1.65 Million - $3.19 Million
202,656 Added 255.82%
281,874 $2.6 Million
Q1 2019

May 15, 2019
SELL
$15.58 - $20.01 $2.14 Million - $2.75 Million
-137,500 Reduced 63.45%
79,218 $1.24 Million
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $2.45 Million - $4 Million
167,821 Added 343.21%
216,718 $3.34 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $448,114 - $545,780
21,278 Added 77.04%
48,897 $1.05 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $64,866 - $95,578
-3,868 Reduced 12.28%
27,619 $672,000
Q1 2018

May 15, 2018
BUY
$16.68 - $22.07 $305,560 - $404,300
18,319 Added 139.12%
31,487 $538,000
Q4 2017

Feb 14, 2018
BUY
$11.23 - $19.1 $145,630 - $247,688
12,968 Added 6484.0%
13,168 $250,000
Q3 2017

Nov 14, 2017
BUY
$15.41 - $32.17 $3,082 - $6,434
200
200 $4,000

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email